Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Balchem stock price, quote, forecast and news

BCPC
US0576652004
905650

Price

162.85
Today +/-
-2.11
Today %
-1.41 %
P

Balchem stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Balchem stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Balchem stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Balchem stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Balchem's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Balchem Stock Price History

DateBalchem Price
8/7/2024162.85 undefined
8/6/2024165.16 undefined
8/5/2024164.27 undefined
8/2/2024171.47 undefined
8/1/2024175.99 undefined
7/31/2024177.46 undefined
7/30/2024178.16 undefined
7/29/2024181.56 undefined
7/26/2024180.78 undefined
7/25/2024174.81 undefined
7/24/2024174.95 undefined
7/23/2024179.69 undefined
7/22/2024175.64 undefined
7/19/2024172.44 undefined
7/18/2024174.03 undefined
7/17/2024174.58 undefined
7/16/2024176.30 undefined
7/15/2024167.94 undefined
7/12/2024166.08 undefined
7/11/2024164.40 undefined
7/10/2024162.89 undefined

Balchem Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Balchem, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Balchem from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Balchem’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Balchem. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Balchem’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Balchem’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Balchem’s growth potential.

Balchem Revenue, EBIT and net profit per share

DateBalchem RevenueBalchem EBITBalchem Net Income
2026e1.08 B undefined0 undefined170.63 M undefined
2025e1.05 B undefined200.19 M undefined161.37 M undefined
2024e990.93 M undefined196.91 M undefined144.01 M undefined
2023922.44 M undefined156.88 M undefined108.54 M undefined
2022942.4 M undefined148 M undefined105.4 M undefined
2021799 M undefined127.9 M undefined96.1 M undefined
2020703.6 M undefined113.1 M undefined84.6 M undefined
2019643.7 M undefined104.9 M undefined79.7 M undefined
2018643.7 M undefined108.9 M undefined78.6 M undefined
2017594.8 M undefined99.1 M undefined90.1 M undefined
2016553.2 M undefined92.3 M undefined56 M undefined
2015552.5 M undefined94 M undefined59.7 M undefined
2014541.4 M undefined82.1 M undefined52.8 M undefined
2013337.2 M undefined65.6 M undefined44.9 M undefined
2012310.4 M undefined59.8 M undefined40 M undefined
2011291.9 M undefined56.2 M undefined20.8 M undefined
2010255.1 M undefined49.8 M undefined33.3 M undefined
2009219.4 M undefined40.7 M undefined26.8 M undefined
2008232.1 M undefined29.3 M undefined19.1 M undefined
2007176.2 M undefined25.9 M undefined16.1 M undefined
2006100.9 M undefined19.2 M undefined12.3 M undefined
200583.1 M undefined16.9 M undefined11 M undefined
200467.4 M undefined12.8 M undefined8 M undefined

Balchem Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.010.010.010.010.010.010.010.010.010.010.010.020.020.030.030.030.030.030.050.060.060.070.080.10.180.230.220.260.290.310.340.540.550.550.590.640.640.70.80.940.920.991.051.08
---28.57-20.0033.3312.5011.1120.00-16.6728.5733.338.337.69-3.5713.7939.3930.431.679.8423.8820.4876.0031.82-5.6016.4414.126.538.7160.532.030.187.418.25-9.3313.6617.90-2.127.385.663.44
28.5714.2940.0040.0050.0037.5033.3340.0041.6741.6742.8633.3337.5038.4639.2939.2941.3842.4236.9638.3334.4334.3333.7334.0026.1422.4130.5930.5929.5528.7128.7826.6230.4332.5531.8231.7332.8131.7230.4129.7232.75---
2122333455669101111121417232123283446526778868997144168180189204211223243280302000
000000011011234455812912161925294049565965829492991081041131271481561962000
-------10.008.33-7.145.568.3311.5414.2914.2917.2415.1517.3920.0014.7517.9119.2819.0014.2012.5018.2619.2219.2419.0319.2915.1617.0316.6416.6716.8016.1716.0715.8915.7116.9219.8019.12-
00000000000011233357581112161926332040445259569078798496105108144161170
--------------100.0050.00--66.6740.00-28.5760.0037.509.0933.3318.7536.8426.92-39.39100.0010.0018.1813.46-5.0860.71-13.331.286.3314.299.382.8633.3311.815.59
--------------------------------------------
--------------------------------------------
22.622.622.622.822.822.822.822.922.923.223.42424.124.224.524.924.724.224.525.125.326.227.127.427.928.528.929.630.230.430.831.231.631.932.232.432.532.532.732.432.45000
--------------------------------------------
Details

Keystats

Revenue and Growth

The Balchem Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Balchem is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000.2000000.100.20.10.71.31.73.13.11.79.212.7135.22.33.446.477.3114.8144.7208.750.384.838.640.454.365.784.6103.266.664.45
0.90.80.60.80.81.31.31.31.61.22.22.63.133.13.3457.17.27.2811.511.629.630.329.132.134.44239.47260.583.391.299.593.498.2117.4131.6125.28
0030000000000000000000000000000000000000000
0.80.70.30.40.51.10.50.910.911.31.91.92.52.92.72.65.67.266.38.59.915.716.61415.718.620.724.849.646.157.260.767.283.970.691.1119.7109.52
0.10.10.20.20.20.30.30.30.50.70.30.50.60.710.90.70.71.22.71.22.12.22.24.953.44.67.94.54.89.46.99.375.31213.410.51814.99
1.81.61.41.41.72.72.12.53.12.83.64.45.85.77.38.49.111.41718.823.629.135.228.952.555.392.9129.7175.7211.9277.7181.3198.3188.4199.3226.3255266.8322.2335.9314.24
2.42.22.22.433.13.33.44.44.55.37.57.87.57.38.17.87.817.925.925.624.224.431.342.142.541.643.444.352.754.9131.6158.5165.8189.8190.9224.2236.5246.8290.8295.9
0000000000000000000000000000000004.64.84.94.554.54.34.08
00000000000000000000000000000000000000000
00000000000.30.40.622.96.15.14.132.21.30.62.16.933.53026.526.622.718.915.1160.4134.9147.5128.1109.4143.9121.794.7213.3191.21
0000000000000000006.66.46.46.413.325.326.426.726.728.528.528.528.5383.9383.9439.8441.4448524529.5523.9769.5778.91
000000000.10.2000.10.100000000000.10.10.10.40.50.50.54.34.12.60.31.84.16.47.210.812.87
00000000000.010.010.010.010.010.010.010.010.030.030.030.030.040.060.10.10.090.10.10.10.10.680.680.760.760.760.90.90.881.291.28
000000.010.010.010.010.010.010.010.010.020.020.020.020.020.040.050.060.060.080.090.150.150.190.230.270.310.380.860.880.950.960.981.161.171.21.621.6
0.10.10.10.10.10.10.10.10.10.10.10.20.20.20.30.30.30.30.30.30.50.80.80.80.81.81.91.91.9222.12.12.12.12.22.22.22.22.12.15
1.71.71.71.71.71.71.71.71.71.71.71.71.81.92.12.833.13.43.53.76.1810.414.317.826.538.649.957.277.597.3122.6137.7151.7165.1174.2173147.7128.8145.65
-0.2-0.30.10.40.71.11.31.92.62.73.245.57.39.912.715.51923.830.836.143.453.36477.894.9118.6147.5181.1214.6251.6295.2344.2388.1464.6528590.9656.7732.1814.5897.49
000000000000000000000000.20.200.2-0.5-0.9-0.80.2-2.7-5.1-6.8-1.6-3.6-5.64.2-5-7.28.69
00000000000000000000000000000000000000000
00000000000.010.010.010.010.010.020.020.020.030.030.040.050.060.080.090.110.150.190.230.270.330.390.460.520.620.690.760.840.880.941.05
0.90.80.60.50.40.90.70.81.41.112.12.52.511.10.611.62.81.31.52.6311.210.310.99.811.514.312.424.414.732.528.533.337.323.756.257.355.5
000000000000001.711.31.82.832.72.74.43.710.56.4101412.71615.424.81821.431.53338.151.665.257.162.03
00000.1000.20.100.20.20.10.30.20.20.40.50.30.40.41.52.22.9446.14.35.307.911.413.512.113.515.716.918.922.225.430.68
0.90.90.40.40.81.10.30.100.60.90.70.4000000000003.22000000000000000
0.30.20.20.20.20.20.20.20.40.40.50.50.50.70.81.20.601.71.71.70007.42.96.81.51.40035353535000.20.20.20.27
2.11.91.21.11.52.21.21.31.92.12.63.53.53.53.73.52.93.36.47.96.15.79.29.636.325.633.829.630.930.335.795.681.2101108.58292.394.4143.8140148.49
0.60.50.60.40.50.30.80.610.612.32.71.40.82.60.7011.39.67.800017.46.703.4000297.5261245.5184156248.6166110.9442.8311.51
0000.20.30.30.40.40.40.40.40.60.70.50.50.50.40.20.41.62.23.546.66.1655.665.95.970.767.274.248.544.356.451.446.562.852.05
00000000000.10.10.10.30.40.30.20.1111110.81.51.61.82.62.83.43.966.76.95.87.414.825.821.240.631.18
0.60.50.60.60.80.61.211.411.533.52.21.73.41.30.312.712.2114.557.42514.36.811.68.89.39.8374.2334.9326.6238.3207.7319.8243.2178.6546.2394.74
2.72.41.81.72.32.82.42.33.33.14.16.575.75.46.94.23.619.120.117.110.214.21761.339.940.641.239.739.645.5469.8416.1427.6346.8289.7412.1337.6322.4686.2543.23
000000.010.010.010.010.010.010.010.010.020.020.020.020.030.050.050.060.060.080.090.150.150.190.230.270.310.380.860.880.950.960.981.171.171.21.621.6
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Balchem provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Balchem's financial health and stability.

Assets

Balchem's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Balchem must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Balchem after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Balchem's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000000000011233357581112161926333840445259569078798496105108
00000000000111222233236788991030404644444551485154
000000000000000001,00001,0000000-1,0000000-11,000-2,000-6,000-28,000-5,000-3,000-4,000-5,000-8,000-10,000
000000000000-1-100-5-10-1-10-8-610-5-70-3804-2-4-5810-2520
000000000000000000000115688879131413111519212827
00000000000000000000001100000466765441125
000000000001111234235569121717141225193025202122253335
0000111001133346310111213161522483944535585103107110118124150160138183
00-1000-10-1-2-1-1-1-100-2-10-2-1-1-2-4-5-3-7-6-13-8-13-42-24-28-19-28-33-37-50-37
00-1000-10-1-3-1-2-1-50-1-16-10-2-1-12-25-45-5-3-11-6-14-8-504-42-133-42-32-156-34-35-416-34
00000000000-10-400-14000-11-23-4000-3000-4910-109-14-12-12702-3653
000000000000000000000000000000000000000
00000000010-102-2-113-1-1-90026-15-4-1-3-10256-35-16-64-6375-85-55300-131
000000000000000-20002011133407811576-160-28-320
00000000010-102-3-313-1-1-70127-16-130-916261-25-19-68-7143-101-102246-153
000000000000000000000000242294720-1000-10
000000000000000000000-1-1-2-2-3-4-110-7-9-10-12-13-15-16-18-20-22
00000000000000010-1730-7-214330373064-15834-46113111818-36-2
0.60.1-0.4-0.20.40.4-0.3-0.1-0.8-0.90.52.61.92.34.15.11.20.18.910.911.914.110.717.844.731.438.339.947.372.261.583.682.59996.1116.7123.188.2145.87
000000000000000000000000000000000000000

Balchem stock margins

The Balchem margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Balchem. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Balchem.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Balchem's sales revenue. A higher gross margin percentage indicates that the Balchem retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Balchem's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Balchem's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Balchem's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Balchem. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Balchem's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Balchem Margin History

Balchem Gross marginBalchem Profit marginBalchem EBIT marginBalchem Profit margin
2026e32.75 %0 %15.77 %
2025e32.75 %19.14 %15.43 %
2024e32.75 %19.87 %14.53 %
202332.75 %17.01 %11.77 %
202229.76 %15.7 %11.18 %
202130.44 %16.01 %12.03 %
202031.82 %16.07 %12.02 %
201932.84 %16.3 %12.38 %
201831.74 %16.92 %12.21 %
201731.78 %16.66 %15.15 %
201632.7 %16.68 %10.12 %
201530.43 %17.01 %10.81 %
201426.63 %15.16 %9.75 %
201328.88 %19.45 %13.32 %
201228.83 %19.27 %12.89 %
201129.46 %19.25 %7.13 %
201030.58 %19.52 %13.05 %
200930.54 %18.55 %12.22 %
200822.66 %12.62 %8.23 %
200726.62 %14.7 %9.14 %
200633.7 %19.03 %12.19 %
200534.54 %20.34 %13.24 %
200435.31 %18.99 %11.87 %

Balchem Stock Sales Revenue, EBIT, Earnings per Share

The Balchem earnings per share therefore indicates how much revenue Balchem has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Balchem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Balchem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Balchem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Balchem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Balchem Revenue, EBIT and net profit per share

DateBalchem Sales per ShareBalchem EBIT per shareBalchem Earnings per Share
2026e33.37 undefined0 undefined5.26 undefined
2025e32.26 undefined0 undefined4.98 undefined
2024e30.57 undefined0 undefined4.44 undefined
202328.43 undefined4.83 undefined3.35 undefined
202229.09 undefined4.57 undefined3.25 undefined
202124.43 undefined3.91 undefined2.94 undefined
202021.65 undefined3.48 undefined2.6 undefined
201919.81 undefined3.23 undefined2.45 undefined
201819.87 undefined3.36 undefined2.43 undefined
201718.47 undefined3.08 undefined2.8 undefined
201617.34 undefined2.89 undefined1.76 undefined
201517.48 undefined2.97 undefined1.89 undefined
201417.35 undefined2.63 undefined1.69 undefined
201310.95 undefined2.13 undefined1.46 undefined
201210.21 undefined1.97 undefined1.32 undefined
20119.67 undefined1.86 undefined0.69 undefined
20108.62 undefined1.68 undefined1.13 undefined
20097.59 undefined1.41 undefined0.93 undefined
20088.14 undefined1.03 undefined0.67 undefined
20076.32 undefined0.93 undefined0.58 undefined
20063.68 undefined0.7 undefined0.45 undefined
20053.07 undefined0.62 undefined0.41 undefined
20042.57 undefined0.49 undefined0.31 undefined

Balchem business model

Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. The company was founded in 1967 and is headquartered in New York. Balchem Corp offers a wide range of products and services, divided into different divisions. The largest divisions are Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. In the Human Nutrition & Health division, Balchem produces ingredients for use in functional foods, supplements, beverages, and other health products. The Animal Nutrition & Health division manufactures animal feed additives aimed at improving the health and growth of livestock. The Specialty Products division produces specialty chemicals for a variety of applications. Balchem Corp is also specialized in the development of fragrances and flavors. Balchem has become one of the leading manufacturers of amino acid derivatives, providing high-quality solutions for veterinary applications. Balchem Corp's history is characterized by expansion and diversification. In its early years, the company focused on the manufacture of chemical additives for the agriculture industry. One of Balchem's first achievements was the development of an additive that prevents feed from molding during transportation and storage. Over the years, Balchem has continuously expanded its offerings and now has a broad product portfolio serving many different industries. Balchem's expansion continued in the 1990s when the company started to expand its business into the human nutrition sector. Today, the Human Nutrition & Health division is the company's fastest-growing segment. Similar to the animal nutrition industry, Balchem also offers a variety of ingredients in this sector that have higher nutrient density and/or better bioavailability than conventional foods. In recent years, Balchem Corp has shown strong growth dynamics. In 2019, the company had a revenue of nearly $650 million. The company has been listed on NASDAQ since 1997 and has continuously increased its market value in recent years. Overall, Balchem Corp is an innovative and diversified company specialized in the manufacture of chemical additives and ingredients for various industries. The company has shown strong growth dynamics over the years and has continuously expanded its portfolio to meet the changing needs of its customers. With its broad product lines divided into different divisions, Balchem has solidified its position as a leading provider of additives and ingredients in many industries. Balchem Corp is a US-based company specialized in the manufacture and sale of chemical additives and ingredients for a variety of industries. Balchem is one of the most popular companies on Eulerpool.com.

Balchem SWOT Analysis

Strengths

Balchem Corp has several key strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality products, particularly in the food and pharmaceutical industries. This reliability has built trust with customers and allowed the company to maintain long-term partnerships.

Secondly, Balchem Corp has developed a diverse product portfolio, offering a range of specialty chemicals, ingredients, and nutritional products. This diversity helps the company mitigate risks associated with dependence on a single product or industry.

Furthermore, the company has a robust research and development department, which enables continuous innovation and adaptation to changing market demands. This focus on technology and product development gives Balchem Corp a competitive edge.

Weaknesses

Despite its strengths, Balchem Corp also faces several weaknesses that could hinder its growth prospects. Firstly, the company may be vulnerable to changes in raw material prices, as the cost of ingredients could impact profit margins. This risk requires effective supply chain management and hedging strategies.

Additionally, Balchem Corp's strong focus on research and development may lead to high operating expenses. While this investment in innovation is necessary for the company's growth, it also puts pressure on profitability and requires efficient cost management.

Lastly, Balchem Corp may struggle with brand awareness in certain markets. As the company looks to expand globally, establishing brand recognition and trust among new consumers may pose a challenge and require strategic marketing efforts.

Opportunities

Several opportunities exist for Balchem Corp to further capitalize on its strengths and expand its market presence. Firstly, the growing demand for health and wellness products provides a chance for the company to leverage its expertise in nutritional solutions and target new customer segments.

Moreover, Balchem Corp could explore strategic partnerships or acquisitions to enhance its product offerings and enter new markets. Collaborations with established players or the acquisition of complementary businesses would provide synergistic benefits and accelerate growth.

Furthermore, expansion into emerging economies presents an opportunity for Balchem Corp, as these markets often have increasing disposable incomes and a rising demand for specialty chemical and ingredient solutions.

Threats

Balchem Corp must also be wary of potential threats that could impact its business operations. Firstly, intense competition within the industry could erode market share and pricing power. The company needs to continuously monitor competitors' strategies and differentiate its products to maintain a competitive edge.

Additionally, regulatory changes and compliance requirements can present challenges, particularly in the food and pharmaceutical industries where Balchem Corp operates. Adapting to evolving regulations and ensuring adherence is crucial to avoid penalties or reputational damage.

Lastly, economic downturns and fluctuations in the global economy could negatively impact demand for Balchem Corp's products. Maintaining a resilient financial position and diversifying its customer base across industries and geographic regions can help mitigate this threat.

Balchem Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Balchem historical P/E ratio, EBIT, and P/S ratio.

Balchem shares outstanding

The number of shares was Balchem in 2023 — This indicates how many shares 32.448 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Balchem earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Balchem's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Balchem’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Balchem's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Balchem Stock splits

In Balchem's history, there have been no stock splits.

Balchem dividend history and estimates

In 2023, Balchem paid a dividend amounting to 0.79 USD. Dividend means that Balchem distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Balchem provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Balchem’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Balchem's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Balchem Dividend History

DateBalchem Dividend
2026e0.86 undefined
2025e0.86 undefined
2024e0.86 undefined
20230.79 undefined
20220.71 undefined
20210.64 undefined
20200.58 undefined
20190.52 undefined
20180.47 undefined
20170.42 undefined
20160.76 undefined
20150.34 undefined
20140.6 undefined
20130.26 undefined
20120.22 undefined
20110.18 undefined
20100.15 undefined
20090.07 undefined
20080.07 undefined
20070.07 undefined
20060.06 undefined
20050.03 undefined
20040.03 undefined

Balchem dividend payout ratio

In 2023, Balchem had a payout ratio of 21.97%. The payout ratio indicates the percentage of the company's profits that Balchem distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Balchem represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Balchem could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Balchem's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Balchem Payout Ratio History

DateBalchem Payout ratio
2026e21.91 %
2025e21.89 %
2024e21.86 %
202321.97 %
202221.85 %
202121.77 %
202022.31 %
201921.22 %
201819.42 %
201715.05 %
201643.43 %
201517.99 %
201435.5 %
201317.93 %
201216.67 %
201126.09 %
201013.39 %
20097.89 %
200810.95 %
200712.64 %
200613.33 %
20056.67 %
20048.6 %
Unfortunately, there are currently no price targets and forecasts available for Balchem.

Balchem latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.06 1.09  (3.25 %)2024 Q2
3/31/20241.03  (3.04 %)2024 Q1
12/31/20230.95 0.95  (0.15 %)2023 Q4
9/30/20230.99 1.04  (5.11 %)2023 Q3
6/30/20230.86 1.06  (23.72 %)2023 Q2
3/31/20230.71 0.94  (31.65 %)2023 Q1
12/31/20220.85 0.94  (10.59 %)2022 Q4
9/30/20220.87 (14.89 %)2022 Q3
6/30/20220.94 1.07  (14.02 %)2022 Q2
3/31/20220.81 1.03  (27.29 %)2022 Q1
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Balchem stock

Eulerpool World ESG Rating (EESG©)

80/ 100

🌱 Environment

72

👫 Social

98

🏛️ Governance

71

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
56,238
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees25
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Balchem list of shareholders

%
Name
Stocks
Change
Date
8.95 % APG Asset Management N.V.2,899,974215,97212/31/2023
5.80 % Wasatch Global Investors Inc1,881,814-28,5953/31/2024
3.74 % State Street Global Advisors (US)1,212,56574,56112/31/2023
3.34 % Conestoga Capital Advisors, LLC1,083,2126,88512/31/2023
2.37 % Geneva Capital Management LLC767,2113,88512/31/2023
2.31 % Geode Capital Management, L.L.C.748,41036,07412/31/2023
2.12 % Dimensional Fund Advisors, L.P.687,48511,62912/31/2023
14.37 % BlackRock Institutional Trust Company, N.A.4,659,961185,61112/31/2023
11.67 % The Vanguard Group, Inc.3,784,40930,86812/31/2023
1.61 % ClearBridge Investments, LLC521,5902,80112/31/2023
1
2
3
4
5
...
10

Balchem Executives and Management Board

Mr. Theodore Harris58
Balchem Chairman of the Board, President, Chief Executive Officer (since 2015)
Compensation 11.95 M
Mr. Martin Bengtsson46
Balchem Chief Financial Officer, Executive Vice President
Compensation 1.67 M
Mr. Martin Reid56
Balchem Senior Vice President, Chief Supply Chain Officer
Compensation 1.1 M
Mr. Jonathan Griffin47
Balchem Senior Vice President, General Manager - Animal Nutrition and Health
Compensation 1.01 M
Ms. Hatsuki Miyata47
Balchem Executive Vice President, General Counsel, Secretary
Compensation 975,667
1
2
3
4

Balchem Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,170,570,790,690,320,75
1

Most common questions regarding Balchem

What values and corporate philosophy does Balchem represent?

Balchem Corp represents a commitment to innovation, sustainability, and to making a positive impact in the industries it serves. The company focuses on delivering high-quality, science-based solutions that provide unique value to its customers. Balchem Corp places a strong emphasis on corporate responsibility, striving to operate in a socially and environmentally responsible manner. With a dedicated team and a customer-centric approach, the company aims to consistently provide exceptional products and services that meet the evolving needs of its clients.

In which countries and regions is Balchem primarily present?

Balchem Corp is primarily present in the United States.

What significant milestones has the company Balchem achieved?

Balchem Corp has achieved several significant milestones in its history. One of the key milestones is its acquisition of certain assets of Animal Nutrition & Health (ANH) business from a leading global food company, AkzoNobel, in 2012. This acquisition allowed Balchem to expand its portfolio and become a leading provider of encapsulated nutraceuticals for both human and animal health markets. Additionally, the company has consistently demonstrated strong financial performance over the years, with increasing revenues and earnings. Furthermore, Balchem has established itself as a trusted name in the industry, known for its high-quality products and innovative solutions.

What is the history and background of the company Balchem?

Balchem Corp is a leading company in the specialty chemicals industry. Founded in 1967, Balchem Corp has established a strong reputation for delivering innovative solutions across various sectors including human and animal nutrition, food and beverage, and pharmaceuticals. The company's rich history spans over five decades, marked by continuous growth and strategic acquisitions. Balchem Corp remains committed to providing high-quality products and services, leveraging its expertise in encapsulation, chelation, and controlled release technologies. With a customer-centric approach and a focus on sustainable solutions, Balchem Corp continues to drive forward in its mission to enhance health and well-being through its diverse portfolio of products and cutting-edge research.

Who are the main competitors of Balchem in the market?

The main competitors of Balchem Corp in the market include companies such as Archer Daniels Midland Company, Innophos Holdings Inc., and Corbion N.V.

In which industries is Balchem primarily active?

Balchem Corp is primarily active in the industries of nutrition and health, animal nutrition, specialty products, and industrial products.

What is the business model of Balchem?

Balchem Corp is a leading company with a unique business model. The company specializes in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to various industries. Balchem Corp focuses on providing innovative solutions that enhance the health and well-being of people, animals, and plants. With a diverse portfolio, the company offers nutritional, flavor, and fragrance ingredients, as well as animal health products and specialty film solutions. Balchem Corp consistently aims to deliver high-quality products and services that meet the evolving needs of its customers, reinforcing its position as a trusted industry leader.

What is the P/E ratio of Balchem 2024?

The Balchem P/E ratio is 36.69.

What is the P/S ratio of Balchem 2024?

The Balchem P/S ratio is 5.33.

What is the AlleAktien quality score of Balchem?

The AlleAktien quality score for Balchem is 8/10.

What is the revenue of Balchem 2024?

The expected Balchem revenue is 990.93 M USD.

How high is the profit of Balchem 2024?

The expected Balchem profit is 144.01 M USD.

What is the business model of Balchem

Balchem Corp is a leading company in the fields of animal nutrition, human nutrition, and industrial chemicals. The innovative company offers a wide range of products and solutions tailored to the needs of its customers. Balchem's animal nutrition division provides solutions for animal feed enhancement, health, and well-being of livestock, pets, and aquaculture. Balchem's products help animal owners improve the health of their animals and increase growth and productivity. Balchem uses innovative technologies to offer its customers powerful and effective feed enhancement solutions that provide significant benefits for animal health and performance. Balchem's human nutrition division offers solutions tailored to the health and needs of the modern consumer. Balchem's products include functional ingredients, vitamins, minerals, and amino acids used in food, beverages, supplements, and pharmaceutical products. Balchem aims to improve human health and well-being by offering innovative products that help consumers maximize their health and happiness. Balchem's industrial chemicals division offers a variety of solutions for applications in agriculture, industry, and other industries. Balchem produces and distributes chemicals that can be used for many different purposes, including pesticides, defoliants, flame retardants, and many more. Balchem leverages its experience and expertise in the chemical industry to offer innovative solutions to its customers, helping them achieve their business goals. An example of a Balchem product is Choline Chloride, which is known as an essential nutrient for animals. It supports the growth and maintenance of cells and tissues, especially the nervous system. It is necessary for the synthesis of lecithin, which is an important component of any cell membrane. Overall, Balchem's business model is based on providing innovative, customer-oriented solutions tailored to the needs of its customers. The company has a strong focus on research and development of new products and technologies, which allows it to continuously enter new markets and remain competitive. By continuously evolving high-quality products and services, Balchem creates value for its customers and supports them in achieving their goals.

What is the Balchem dividend?

Balchem pays a dividend of 0.71 USD distributed over 1 payouts per year.

How often does Balchem pay dividends?

Balchem pays out a dividend 1 times a year.

What is the Balchem ISIN?

The ISIN of Balchem is US0576652004.

What is the Balchem WKN?

The WKN of Balchem is 905650.

What is the Balchem ticker?

The ticker of Balchem is BCPC.

How much dividend does Balchem pay?

Over the past 12 months, Balchem paid a dividend of 0.79 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Balchem is expected to pay a dividend of 0.86 USD.

What is the dividend yield of Balchem?

The current dividend yield of Balchem is 0.49 %.

When does Balchem pay dividends?

Balchem pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Balchem?

Balchem paid dividends every year for the past 23 years.

What is the dividend of Balchem?

For the upcoming 12 months, dividends amounting to 0.86 USD are expected. This corresponds to a dividend yield of 0.53 %.

In which sector is Balchem located?

Balchem is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Balchem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Balchem from 1/19/2024 amounting to 0.79 USD, you needed to have the stock in your portfolio before the ex-date on 12/26/2023.

When did Balchem pay the last dividend?

The last dividend was paid out on 1/19/2024.

What was the dividend of Balchem in the year 2023?

In the year 2023, Balchem distributed 0.71 USD as dividends.

In which currency does Balchem pay out the dividend?

The dividends of Balchem are distributed in USD.

All fundamentals about Balchem

Our stock analysis for Balchem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Balchem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.